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INTRODUCTION
In clinical studies of the beneficial influence of quinin salts and
allied compounds in the pneumonias of man, three facts stand out:
( 1) The relief to toxic symptoms without appreciable influence on
the evolution of physical signs, (2) the change of termination from
crisis to lysis, and (3) the absence of cinchona poisoning, even when
enormous doses are given. (This does not apply to ethylhydrocuprein,
however). There is nothing in the known pharmacologic influence of
quinin as a function modifier that will account for either the first or
the second of these facts. Nor can bactericidal action alone explain
them. The third fact indicates the presence of a quinin-tolerance in
the subjects of pneumonia.
Hence the hypothesis has been put forth of a possible neutralizing
influence of the drug; i. e., a mutual antagonization or inhibition,
physical or chemical, direct or indirect, of quinin by pneumonia
poison-complex, and of pneumonia poison-complex by quinin.'
The term pneumonia poison-complex rather than pneumotoxin, has
been used, because it is not accurately known just what are the poisons
present in pneumonia-whether they are all of microbic origin directly
or indirectly, or whether they are produced in part or in whole by the
human organism. The main facts being unknown, the details as to
site of production, manner of distribution, chemical and biologic
nature, action, etc., can only be conjectured; and no opinion can be
Received for publication Jan. 9, 1918.
Aided by the Fe!s grant for research in pneumonia.
1 Solis-Cohen, S.: N. Y. Med. j our., 1916, 103, p. 1065.
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ACTION OF QUININ, ETC., ON "PNEUMCTOXIK" 477
hazarded as to whether the poisons belong wholly to offensive reac-
tions or in part to defensive ones.
To test the hypothesis of the special relation of pneumonia poisons
to quinin, therefore, involves much groping in the dark, in the process
of establishing or eliminating various possibilities; and an endeavor
to find the poison or poisons in question should logically precede such
investigations.
It has been deemed practicable, however, to pursue the two lines
of research together, partly in the hope that one might throw light on
the other; and partly that at least certain preliminary questions as to
the possible action of quinin might be determined.
THE PNEUMOTOXIN
In the attempt to isolate the substance responsible for the toxic
symptoms in the pneumonias of man, investigators have focussed
their attention on the pneumococcus. Neufeld and Dold- showed that
by the action in vitro of complement on the precipitate resulting from
the addition of pneumococci to the corresponding immune serum, a
toxic substance is produced which, on primary intravenous injection
into guinea-pigs produces anaphylactic-like symptoms and death.
They concluded that this anaphylatoxin of Friedberger" is set free by
the body fluids and that pneumonia is a "mild and protracted form of
anaphylaxis." Vaughan and Wheeler" give a similar explanation,
based on their studies of protein products. Rosenow" thinks that the
autolytic products of the pneumococcus which he demonstrated in
vitro in the absence of serum, and which are similar in their properties
to the anaphylatoxin of Friedberger, are liberated in vivo by the fer-
ments in the bacterial cell. But as pointed out by Cole, who gives a
complete review of the literature," the symptoms produced by the
injection of anaphylatoxin or bacterial extract resemble very remotely
those presented during a pneumococcus infection. Furthermore, Cole
found that even when autolysis of the pneumococci is prevented by
dissolving large masses of them in sodium choleate, a highly toxic and
hemolytic substance is liberated which produces anaphylactic symp-
toms and death on primary injection into guinea-pigs. He concludes
that the pneumococcus poison exists preformed in the bacterial cell
a Dold, H.: Das Bakterienanaphylatoxin, 1912.
a Ztschr. f. Immunitiitsforsch., 1909, 2, p, 208; 3, p. 692; 1910, 4, p. 636.
4 Jour.. Infect. Dis., 1907, p. 476.
5 Ibid., 1911, 9, p. 190; 1912, 10, p. 113.
e Jour. Exper. Med., 1912, 16, p. 644.
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478 S. SOLIS-COHEN, C. WEISS, AND J. A. KOLMER
and that its liberation depends not on the action of its own autolytic
ferments, but on the dissolution of the pneumococcus by the body
fluids.
What part this endocellular pneumococcus toxin plays in the
symptom-complex and changes in pneumonia is a matter of conjecture.
It is possible that its continuous liberation in vivo (presumably accom-
plished with facility by the action of the tissue enzymes: trypsin,
leukoproteases, etc.) may result in the initial toxemia manifest in
general disturbances such as cardiac, respiratory and vasomotor symp-
toms. The pneumotoxin, moreover, increases the permeability of the
walls of the capillaries lining the alveoli for the various blood proteins,
erythrocytes, leukocytes, fibrin and enzymes. Friedrich Muller" has
shown that the enzymes in the exudate are introduced from without
and are foreign to the lung tissue. These normal constituents of the
circulating body fluids, when transferred to and accumulated in the
alveolar spaces form the exudate. We have shown elsewhere" that the
pneumonic exudate is composed of normal serum proteins. The
extreme leukocytosis- in pneumonia favors this phenomenon.
With the body fluids depleted of their normal proteins, there is a
diminution in their osmotic pressure, as shown by Sandelowsky,"
Achard, Tourraine and Saint Girons," Epstein.P and Rowe." To
compensate for this there is the retention of chlorids, long clinically
known and recently studied by Rowntree;" Medigreceanuv' and Pea-
body," which keeps the osmotic pressure constant.
It may be further assumed that pneumococci proliferating in the
body fluids liberate the pro ferments that initiate the autolysis of the
fibrin, leukocytes, etc., in the lung. Taylor?" points out that bacterial
extracts and tissue juices activate pro ferments such as propepsin. . The
toxic products, however, tend to inhibit this autolysis with the produc-
tion of only partly digested products such as albumoses, proteoses and
peptones, as observed by Turro," Matthes," Levaditi," Poucher," and
1 Verhandlung der Naturforschenden Gesellschaft in Basel, 1902, 13.
• Weiss, Charles, et aJ.: The Mechanism of the crisis in pneumonia (to he published).
• Deutsch. Arch. f. klin. Med., 1909, 96, p, 455; 1910, 100, p. 324.
'" Arch. de Med. Exper. et d'anat. Path., 1912, 24, p. 647.
It Am. Jour. Med. Sc., 1917, 154, p, 638.
12 Arch. Int. Med., 1917, 18, p. 455.
ia Bull. Johns Hopkins Hosp., 1908, 19, p. 367.
14 Jour. Exper, Med., 1911, 14, p. 289.
" Jour. Exper. Med., 1913, 17, p. 71.1. Digestion and Metabolism, 1912.
11 CentralbJ. f. BakterioJ., 1912, 32, p. 105.
ae Arch. f. expo Path. U. Pharm., 1895, 36, p. 437.
ta Ann. de l'Tnst. Pasteur, 1903, 17, p. 187.
2Q 1883, 96, p. 1506 and 1601.
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ACTION OF QUININ, ETC., ON "PNEUMOTOXIN" 479
Auld;" These products are toxic. They aid in further inhibition of
autolysis and when absorbed, increase the coagulation time of the
blood, as shown by Dochez," Hayem," Pye-Smith," and Coleman."
Opie" has furthermore shown that the serum of inflammatory exu-
dates retards the action of the autolytic enzymes within the leukocytes.
The period of accumulation of greatest amount of pneumotoxin
and hence of toxic albumoses, proteoses, etc., is the period of the
crisis. As the pneumococci continue to proliferate, the increasing
amount of acid (as pointed out by Netter, Bougault and Salanier,"
and of bactericidal substances in the exudate (observed by Conradi'"')
combined with the phagocytic action of the leukocytes (Lamar and
Meltzer;" Tschistovitch,"? Winternitz and Hirschfelder," Winternitz
and Kline'"}, and the production of various antibodies (observed by
Clough," Dochez;" Jobling;" Rosenow," Cole," Bu1l3 7 and others)
checks their growth and toxin production. That antibodies may be
formed to the toxin itself in addition to other antibodies, is suggested
by the increase of the globulins of the serum (Rowe'" and Epstein'"},
a phenomenon which is generally found to be associated with antibody
formation, as shown by Hurwitz and Meyer;" Banzhaf and Gibson,"
Gibson and Collins-' and others.
Moreover, the continuous action of the toxins, aside from anti-
body production, changes the primary inhibitory effect on autolysis
into an accelerating one. This is suggested by the work of Hess and
21 Selected Researches in Pathology, 1901.
aa Jour. Exper. Med., 1912, 16, p. 693.
23 Du sang et de ses alterations anatomiques, 1889.
24 Allbut and Rolleston, System of Medicine, 1898, 5. p. 91.
" Biochem. Jour., 1907, 2, p. 184.
26 Jour. Exper. Med., 1905, 7, p. 316.
21 Compt. rend Soc. de Bio!., 1917, p. 80, and 97.
28 Beitr. z, Cbern. Physicl. u. Path., 1901, 1, p. 193.
29 Jour. Exper. Med., 1912, 15, p. 133.
30 Ann. de l'Inst. Pasteur, 1890, 4, p. 285; 1904, 18, p. 304.
31 Jour. Exper. Med., 1913, 17, p. 657.
aa Ibid., 1915, 21, p. 320.
83 Bull. Johns Hopkins Hosp., 1913, 24, p. 295.
84 Jour. Exper. Med., 1912, 16, p. 665.
ss Ibid., 1915, 22, p. 568.
86 Ibid., 1914, 20, p. 346.
3T Ibid., 1915, 22, p. 457.; 1916,24, p. 7.
.. Ibid., 1912, 16, p. 719; 1913, 17, p. 444; 1914, 20, p. 334.
ee Ibid., 1916, 24, p. 515.
40 Ibid., 1910, 12, p, 3. Gibson and Farnulaner, L. W.: Collected Studies, Bureau of
Laboratories, Dept. of Health, City of New York, 1915, 8, p. 208.
" Jour. Bio!. Chem., 1907, 3, p. 232.
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480 S. SOLIS-COHEN, C. WEISS, AND J. A. KOLMER
Saxl." This accelerated autolysis in tum hastens antibody production
as pointed out by Blum." The products of autolysis are now com-
pletely digested proteins in the amino-acid stage which are nontoxic
and easily absorbed and eliminated.
The transition from inhibitory to accelerating action of pneumo-
toxin on autolysis is governed by the laws of mass action. Hence the
change from febrile toxemia to the afebrile atoxic state is necessarily
an abrupt one - crises. The period is marked by the sudden drop in
temperature and relief from toxemic symptoms and return to normal
coagulation time of the blood. It is clinically a period of peril, and
may terminate in death-a fact not to be lost sight of in analysis or in
experimental study. If successfully passed, resolution sets in, with
removal (autolysis) of exudate.
The autolysis is probably accomplished by the normal proteolytic
enzymes of the body. Hartman" suggests that the fibrin requires
specific antibodies for its removal, and Ascoli'" is of the opinion that
isolysins are formed to remove the cellular constituents. He demon-
strated such isolysins after the crisis.
That the pneumotoxin exerts no influence on the lung tissue itself
and that the latter plays no part in the formation of the exudate is
well known, as mentioned by Wells." Our own observations" based
on various anaphylactic and chemical studies substantiate this.
Views similar to this have been expressed by Hedin," Opie'"
Jobling and Peterson," Dick," Hektoen," and Falls." At present we
are engaged in subjecting the various phases of our hypothesis to
experimentation.
The opinion that the exudate plays an important and specific role
iri lobar pneumonia is indicated by the work of Rosenow and Arkin'"
who showed that extracts of pneumonic lungs injected intravenously
into dogs delay the coagulation time of the blood, and produce symp-
toms simulating anaphylaxis. Our own, work on the comparative
toxicity of normal and pneumonic lungs described elsewhere" demon-
" Wiener klin, Wchschr., 1908, 21, p. 248 and 486.
43 Beitr, z. chem. Physiol. u. Path., 1904, 5, p. 142.
.. Jour. Infect. Dis., 1913, 13, p. 69 and 499.
43 Miinchen. med. Wchnschr., 1901, 48, p. 1241.
.6 Chemical Pathology, 1914.
" Ztschr, f. physiol. Chem., 1907, 52, p. 412.
" Jour. Infect. Dis., 1912, 10, p. 383.
.. Jour. Am. Med. Assoc., 1914, 62, p. 254.
so Jour. Infect. Dis., 1915, 16, p. 466.
'" Jour. Infect. Dis., 1912, 11, p. 480.
" Kolmer, J. A., Weiss, C., and Steinfield, E.: Jour. Infect. Dis., 1918, 22, p. 469.
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ACTION OF QUININ, ETC., ON "PNEUMGTOXIN" 481
strates the toxicity of the pneumococcus exudate. We have, further-
more, obtained specific anaphylactic reactions in guinea-pigs sensitized
to such extracts. We shall report on this and other corroborative
evidence in another paper."
These two substances, the pneumococcus hemotoxin and the toxic
extract of a pneumonic lung, seemed to afford a point of attack in the
problem of the action of quinin on pneumococcic poisons in general,
and the observations which are set forth in detail in this paper were
made to determine whether any neutralizing action could be demon-
strated.
1. Is THERE A NEUTRALIZING POWER OF QUININ AND ITs
CONGENERS ON PNEUMOTOXIN?
Technic of Preparation of Pneumotoxin.-The demonstration of an endo-
cellular toxin in the pneumococcus is fraught with many difficulties. The
virulence of the organism, the mediums in which it is grown, the temperature
and time of incubation, the amount of autolysis, the presence of traces of broth
proteins, the thickness of the emulsion of pneumococci, the volume of choleate
used, and a host of other details determine the success or failure of the prepa-
ration of the pneumococcus toxin. In spite of the fact that we followed in
detail the precautions mentioned by Cole, we were unable to produce uniformly
a toxin which was hemolytic and also produced anaphylaxis on primary intra-
venous injection in guinea-pigs. Our results with rats were almost uniformly
negative, probably due to the extremely high tolerance of the rat for anaphyla-
toxins. This subject has been recently studied by Novy and his associates."
The organism used was pneumococcus Type I obtained from Dr. Rufus Cole.
It was grown in tubes of beef infusion broth containing 0.1% glucose and 1%
Witte's peptone to which was added a drop of freshly defibrinated human, horse
or rabbit blood. The reaction of the medium was slightly alkaline to phenol-
phthalein.
It was found advisable, in order to obtain a luxuriant and virulent culture,
to transplant every other day, and from time to time, to pass the organism
through a mouse. In this way the M. L. D. for mice (24 hours) was kept
constantly at 0.000,000,1 c c of a 24-hour broth culture.
The technic employed was briefly as follows: 1,000 to 1,500 c c of a 24-hour
broth culture was centrifugalized for 30-60 minutes at high speed. The bacterial
sediment was washed once in salt solution (0.85%) and after a second centri-
fugalization the supernatant fluid was completely removed. To the sediment
were added 5 c c of salt solution and 5 c c of a mixture of 2% solutions of pri-
mary and secondary sodium phosphate (1: 8). To the thick emulsion thus
obtained was added 1-2 c c of a 2% solution of sodium choleate (in normal salt
solution). This mixture was placed in a 37 C. water-bath for one-half hour
and frequently stirred; the total volume was now made up to 75 or 100 c c with
salt solution and the resulting mixture kept in the refrigerator until used.
A control fluid containing sodium choleate and primary and secondary sodium
phosphate was prepared in exactly the same way. The volume of pneumococcus
emulsion was of course replaced by salt solution.
•• Navy, DeKruif, et al.: Jour. Infect. Dis., 1917, 20, p. 498.
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482 S. SOLIS-COHEN, C. WEISS, AND J. A. KOLMER
The Toxicity of Pneumotoxin by Animal Injection.-The toxicity of the
pneumotoxin was tested by intravenous injection in guinea-pigs and white rats
and by intraperitoneal injection in white mice. When injecting pneumotoxin
intraperitoneally into mice, it became extremely important to culture the fluid
for purpose of ascertaining whether or not any pneumococci had escaped solu-
tion in the sodium choleate, and also to culture the heart's blood of all mice
dying as a result of injection. The results are given in Tables 1 and 2.
TABLE 1
TOXICITY OF PNEUMOTOXIN BY INTRAVENOUS INJECTION IN GUINEA-P,GS *
Pneumo-
toxiu
No.
Weight of
Animal
in Grams
Dose
Injected
in Cc
Results
------------------- -----------------
1
1
1
Control fluid 1
2
2
2
2
2
Control fluid 2
Control fluid 2
9
9
10
10
10
350
400
320
315
210
205
200
205
200
ISO
205
265
270
310
300
255
6
6
6
n
2
2
2
5
2
2
3
8.5
5.5
6.5
5.5
4.5
Immediate anaphylactic death
Anaphylactic symptoms with death in 24hrs,
Anaphylaetle symptoms with death in 24 hrs.
No symptoms
Died. 24 hours
Died. 24 hours
Died. 48 hours
Died. 24 hours
Died. 72 hours
Died. 24 hours
Died. 24 hours
Dyspnea; died in 5 days
Slight toxic symptoms; recovered
Severe dyspnea; recovered
Moderate shock
Mild dyspnea; recovered
* All animals were observed for a period of one week.
TABLE 2
TOXICITY OF PNEUMOTOXIN BY INTRAPERITONEAL INJECTION
Mice Rats
---
Pneu- Weight Dose Pneu- Weight Dose
mo- of Ani- per Results mo- of Ani- per Results
toxin malin 100 toxin malin 100
No. Grams Grams No. Grams Grams
-------
---
--_.
4 19 1.0 Died, 24 hours 6 84 5.0 Dyspnea; recovered
4 20 0.5 Died, 24 hours 6 81 4.0 No symptoms
4 20 0.00 Died, 24 hours 6 82 2.5 No symptoms
Contral 6 75 2.0 No symptoms
fluid 4 20 1.0 Survived Control
fluid 6 70 4.0 No symptoms
The Neutralizing Power of Quinin and Its Compounds on Pneumotoxin in
Vivo.-After having thus determined the lethal dose of each preparation of
pneumotoxin, we attempted to neutralize its toxicity by means of the various
cinchona derivatives, using the following methods: .
1. In Vitro: The toxin and drug were mixed in the test tube in proper pro-
portions and incubated either at room temperature or at 37 C. for 1, 2 or 3
hours and injected. The in vitro method had to be abandoned for it was observed
that sodium choleate, protein solutions and colloidal suspensions (such as agar,
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ACTION OF QUININ, ETC., ON "PNEUMOTOXIN" 483
saponin and gum mastic) as well as serum will precipitate quinin. The latter
substance is mentioned by MacGilchrist."
2. In Vivo: The proper amount of drug was injected into the animal 2 or
more hours before the injection of the toxin.
The results are summarized in Tables 3 and 4.
TABLE 3
NEUTRALIZING POWER OF CINCHONA DERIVATIVES FOR THE TOXICITY OF PNEUMOTOXIN
Results
Anaphylactic; death
5 minutes
Died 24 hours
No symptoms
]1;0 symptoms1.5
1.5
1.5
Dose of
Quinin per
60 Kilo
Quinin Salt
Ethylhydrocuprein
hydroehlorid
Quinin and urea
hydrochlorid
EthyIhydroeuprein
hydroehlorid
Quinin and urea
hydrochlorid
5cc
Control
Control 0
193
195
195
185
Weight of
Animal
in Grams
~pneumotoxin II
No, Dose
----1----- ---~---·_--------\-----1--------
5ec I
Pneumotoxin and qunnn salt were incubated at room temperature, for one hour and
injected intravenously into guinea-pigs.
TABLE 4
KEUTRALIZI:-;G POWER OF CINCHONA 'DERIVATIVES FOR THE TOXICITY OF PNEUMOTOXIN
Xame of Salt
I
Weight in [-------
Grams I
I
Dose of GinChO_n_a =J
Grams per I
60 Kilo
Results
In Vitro
18
16
19
21
Ethylhydrocuprein hydroehlorid
EthyIhydrocuprein hydrochlorid
Quinin and urea hydroehlorld
Quinin and urea hydroehlorld
2.0
1.0
2.0
1.0
Died, 24 hours
Died, 24 hours
Died, 24 hours
Died, 24 hours
In Vivo
16
20
18
18
Ethylhydrocuprein hydrochlorid
Ethvlhydroeuprstn hydrochlorid
Quinin and urea hydrochlorid
Quinin and urea hydrochlorid
1.0
0.5
1.0
0.5
Died, 24 hours
Died, 24 hours
Died, 24 hours
Died, 24 hours
In Vitro Tests: 2 M.L.D. of pneumotoxin were incubated at 37 e c for 2 hours with the
proper dose of quinin and injected intraperitoneally into mice. In Vivo Tests: The proper
dose of quinin was injected intraperitoneally and 2 M.L.D. of the pneumotoxin were given in
the same way. Controls: Receiving the doses of quinin glven in the tables survived; those
receiving the pneumotoxin alone died.
As shown in the tables, the cinchona derivatives do not exert any
gross neutralizing action on the toxicity of pneumococcus toxin. In
vivo experiments conducted with guinea-pigs gave negative or incon-
stant results. It was thought highly desirable to study the effect of the
repeated injection of sublethal doses of the pneumotoxin followed by
" Scient. Mem. Off. Med. and Sanit. Depts., India, 1911, No. 41.
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484 S. SOLIS-COHEN, C. WEISS, AND J. A. KOLMER
similar doses of the cinchoma derivatives. This slower method of
absorption approaches more closely the condition in human pneumonia.
But because of the difficulty of preparing the pneumotoxin and of its
extreme lability and rapid deterioration this procedure was found
impracticable.
Hemolytic Activity of Pneumotoxin.-ColeS8 showed that the toxin liberated
by the dissolution of washed pneumococci in sodium choleate was hemolytic
for red blood cells. He found that various normal serums, solutions of egg
albumin, cholesterin, lecithin, and trypsin will destroy this hemolytic power;
that the inhibitory power of serum of pneumonic patients was no greater than
of normal serum.
We attempted to demonstrate any neutralizing action of various quinin salts
in relation to the hemolytic action of the pneumotoxin, in the hope that it would
throw some light on the influence of the cinchona derivatives in the treatment
of pneumonia.
Technic of Hemolytic Tests.-Fresh guinea-pig corpuscles washed free from
serum were used in a 1% suspension in salt solution, and in constant dose
of 1 c c.
Toxin or poison was made up with salt solution into proper dilution and
pipetted in doses ranging from 0.1-2 c c.
The total volume in each tube was 3 c c.
Incubation was effected either in a 37 C. water bath for I hour or in a dry
incubator at 37 C. for 2 hours.
Readings were made at the end of the period of incubation and again after
the cells have settled down in the refrigerator over night.
The results obtained are illustrated in Table S.
TABLE 5
THE HEMOLYTIC ACTIVITY OF PNEUMOTOXIN
Dose of Pneumotoxin 0 c
Substance
0.1 0.3 0.5
1-
0.7 1.0
1
1.5 2.0
Pneumotoxin 1 NH NH NH NH NH NH NH
Control fluid 1 NH NH NH NH NH NH NH
Pneumotoxin 2 I VSH aH aH MH MH I OH CHOontrol fluid 2
I
NH NH NH I NH NH I SR OHPneumotoxin 3 NH NH OH
I
OH OH OH OR
Oontrol fluid 3 NR NR NR NH NH OH OR
Pneumotoxln 3' VSR VaR OR OR OR OR OR
Control fluid 3 NR NR NR I NH OH OH OR
Pneumotoxin 4 NR NR NR
!
NH NH NR NR
Oontrol fluid 4 NH NH NR NH NH NH NR
Pneumotoxin 5 NR NH NR SH MR OH OH
Oontrol fluid 5 NH NH NR SH OH OH OR
Pneumotoxin 6 NR NH SR MH OR OR OH
Oontrol fluid 6 NR NH SR OH OH OR OR
Pneumotoxin 7 MR OH OH CH O.H OR OH
Oontrol fluid 7 NR NH NR MR OH OR OR
Pneumotoxin 9 OH OH OR OR OR I OR OROontrol fluid 9 NH NH SH
I
MR OR I OR OR
Pneumotoxln 10 NH NH NH VMH OR I OR OH
Oontrol fluid 10 NR I NH
.
SR MH OH I OH OHI I
NR =no hemolysis; VSH =very sUght hemolysis; SH =slight hemolysis; MH =marked
hemolysis; VMH = very marked hemolysis; OR = complete hemolysis.
* This pneumotoxln was retested after one week's storage in the refrigerator.
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ACTION OF QUININ, ETC., ON "PNEUMOTOXIN" 485
As shown in Table 5, four of the pneumotoxins (2, 3, 7, and 9) showed a
more marked hemolytic activity for guinea-pig cells than the control fluids.
Cole points out that the hemolytic and toxic properties of a solution of pneu-
mococci in sodium choleate are not always concomitant. Our findings confirm
this opinion. From the results of our attempts at preparing pneumotoxin we
are led to believe that the glucose in the culture medium, while essential for
the production of the hemolytic properties, interferes with the liberation of the
toxic constituents by producing cholic acid from the sodium choleate (Table 6).
TABLE 6
SUMMARY OF THE TOXIC AND HEMOLYTIC PROPERTIES OF VARIOUS PREPARATIONS
OF PNEUMOTOXIN
Pneumo- Volume of Per Cent. of Degree of Hemolytic
toxin Broth in GlucoseIn Toxicity Activity
No. CC Broth
1 1000 0.1 +++ None
2 1500 0.1 ++ ++
3 1000 0.1 0 +++
4 I 2000 0.1 + None
5
I
1500 None + ±
6 1500 None + ±
7 I 1500 0.03 0 +++
9 I 1400 0.1 + +++
10 , 1400 None + +
I
+++ Very marked hemolytic activity or toxicity.
++ marked hemolytic activity or toxicity.
+ slight hemolytic activity or toxicity.
± doubtful (hemolytic activity no greater than control fluid).
o =not determined.
The Neutralizing Power of Cinchona Derivatives for the Hemotoxin of
Pneumococci in Vitro.-In the course of our studies on the neutralizing power
of the cinchona derivatives for the hemotoxin of pneumococci, we observed that
the solutions of quinin used (l% in salt solution) were of themselves very
hemolytic. This hemolytic activity was partly due to the free acid present in
the various soluble salts of quinin. It was found impossible to neutralize this
acidity, since the quinin would precipitate on the addition of alkali. The fol-
lowing technic was therefore adopted: The hemolytic activity of the various
quinin salts in 0.1% and I% solutions, of the toxin and of the control fluid was
titrated for guinea-pig cells. In one series of test-tubes were placed the largest
nonhemolytic doses of the various quinin salts; in a second series the smallest
hemolytic dose, in a third gradually increasing doses. To each tube of Series
1 and 2 were added increasing doses of toxin. Each tube of Series 3 received
3 M. H. D. of pneumotoxin. The same procedure was repeated using the
control fluid. We found that the quinin salts exerted no inhibition on the
hemolytic activity of pneumotoxin. In fact the reverse phenomenon, a sum-
mation of hemolytic powers was observed.
II. THE INFLUENCE OF CINCHONA DERIVATIVES ON THE TOXIC SUBSTANCES
OBTAINABLE FROM PNEUMONIC LUNGS
Preparation of Lung Extracts.-A report of the method of preparation, the
comparative toxicity and biologic specificity of human pneumonic lung extracts
is given in another communication." We wish here briefly to indicate the technic
and the results of attempts to neutralize the toxic substance in such extracts:
A pneumonic lung in the stage of gray hepatization was obtained as soon as
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486 S. SOLIS-COHEN, C. WEISS, AND J. A. KOLMER
possible after necropsy; smears were made from various sections and stained
for pneumococci by Gram's stain. The lung tissue was passed through a meat
grinder, ground up in a mortar with washed quartz sand and finally squeezed in
a Buchner press with a force of 250 kg. per square centimeter. The juice thus
obtained was centrifuged, filtered through paper and preserved in the refrig-
erator with 0.5% phenol. Injections were made in guinea-pigs, mice and rabbits
by intraperitoneal and intravenous routes.
We found that the exudate of human pneumonic lung is highly toxic, pro-
ducing anaphylactic-like symptoms in guinea-pigs and rabbits and paralysis on
repeated intramuscular injection in the latter. This last observation suggests
the presence of a toxic albumose such as demonstrated by Auld'! in the tissues
of rabbits dying of pneumonic infections.
Summary of the Neutralizing Power of Cinchona Derivatives for the
Toxicity of Pneumonic Lung Extmcts.-Using both in vitro and in vivo methods
it was found that quinin hydrobromid exerted a very marked neutralizing action
on the toxicity of pneumonic lung extracts in that therapeutic doses prolonged
the life of the animal up to five days or more after the injection of 1 M.L.D.
of the extract; quinin hydrochlorid, quinin and urea hydrochlorid and ethyl-
hydrocuprein hydrochlorid afforded little or no protection. The results are
shown in Tables 7, 8, and 9.
TABLE 7
THE NEUTRALIZING POWER OF VARIOUS CINCHONA DERIVATIVES ON THE TOXICITY OF
PNEUMONIC EXUDATES IN GU,NEA-P,GS
Weight of
Animal in
Grams
175
195
215
200
215
210
Cincbona Compound
Etbylbydrocuprein bydrochlorid .
Quinin and urea bydrocblorid .
Quinin bisulphate .
Quinin hydroehlorid .
Hydroquinin bydrochlorid .
Quinin hydrobromid .
Results
Died at once
Died in 30 minutes
Died in 6 days
Died in 2 days
Died at once
Died in 5 days
One M.L.D. of pneumonic lung extract was incubated for 2 bours at 37 C. with a dose of
cincbona equivalent to 1 grn. per kilo of body weight and injected Intravenously.
TABLE 8
THE NEUTRALIZING POWER OF VARIOUS CINCHONA DERIVATIVES ON THE TOXICITY OF
PNEUMONIC EXUDATES IN MICE
Welgbt in Clncbona Derivative Grams of Drug Results
Grams per 60 Kilo
24 Ethylhydrocupreln hydrochlorid.............. 2.0 Died, 24 hours
21 Ethylhydrocuprein hydrocblorld.............. 1.0 Died, 24 hours
17 Quinln and urea bydrochlorid................ 2.0 Died, 24 hours
17 Quinln and urea hydrochlorid................ 1.0 Died, 24 hours
14 Qu!n!n b!SUIPhate............. · ............... 1 2.0 Died, 24 hours
18 QUlnm bisulphate............................. 1.0 Died, 24 hours
Mice were injected intraperitoneally with 32 M.L.D. of the lung poison 2 hours after tbe
administration of the drug. Controls receiving the drugs alone survived. Controls receiving
pneumonic lung extract alone died In 24 hours.
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TABLE 9
NEUTRALIZING POWER OF CINCHONA DERIVATIVES FOR THE TOXICITY OF PNEUMONIC
EXUDATE IN RABBITS
Weight
of
Animal
Cinchona Derivative
Dose of
Cinchona in
Grams per
60 Kilo
Results
-~~- ------------------- .-------------
1280
1400
1300
1040
750
1200
Ethylhydrocuprein hydrochlorid .
Ethylhydrocupreln hydroehlorld .
Quinin and urea hydroehlorld ..
Quinin and urea hydrochlorid .
Quinin hydrobromid .
Quinin hydrobromid ..
0.5
0.2
0.5
0.2
0.5
0.2
I
Died in 24 hours
Died in 24 hours
Died in 24 hours
Died in 24 hours
Died in 24 hours
Survived
Rabbits were injected into the muscle of the leg-quinin and toxin being given simultane-
ously in opposite legs. The dose of poison was uniformly 1 C'c per kilo. Controls receiving
the doses of quinin alone survived.
Hemolytic Activity of Extracts of Human Pneumonic Lungs.-Using the
technic described under the heading-pneumotoxin-it was found that the pneu-
monic lung extracts were markedly hemolytic for guinea-pig erythrocytes, the
M.H.D. being in one case 0.3 c c of a 1: 100 dilution. Control experiments
with normal (nonpneumonic) lungs were very slightly lytic in 1: 50 dilution.
Summary of Antihemolytic Activity of Quinin Salts.-The results of the
studies on the inhibitory effect of the cinchona derivatives on the hemolytic
activity of pneumonic exudates were very difficult of interpretation. Using
dilutions of these salts in doses ranging from 0.00001 to 0.002 gm. and 1 M.H.D.
of poison we found that ethylhydrocuprein hydrochlorid, quinin, and urea hydro-
chlorid, gave a slight inhibition when large doses (of themselves hemolytic)
were used. Quinin hydrochlorid, quinin hydrobromid, quinin bisulphate, and
hydroquinin hydrochlorid behaved in a reverse way, giving marked inhibition
in nonlytic doses and no inhibition in lytic doses. The ease of precipitation of
the former salts in the presence of protein solutions and the greater solubility
of the latter in protein solutions are factors entering into an explanation of
this phenomenon. Sherwood" has recently studied this subject.
The Occurrence of Toxic Substances in the Blood of Pneumonic Patients.-
Attempts to detect toxic substances in the blood of pneumonic patients have
been made by numerous workers. Cole' has shown that the filtered active serum
of a rabbit dying of a very severe pneumococcic septicemia does not contain
any demonstrable toxins. Knowing that the Berkefeld filter retains toxic
albumins, complement and various large protein molecules" 57 we repeated this
experiment, using the unfiltered serum but were unable to produce anaphylactic
symptoms in a rabbit. Rosenow,' on the other hand, has obtained anaphylactic
reactions by the primary injection of pneumonic serum which was allowed to
autolyze at ice-box temperature for one week.
Since pneumococcic septicemia in rabbits and mice differs greatly from lobar
pneumonia in man, we thought it might be possible to detect in human blood
toxic substances derived either from the autolysis of the pneumococci or
the leukocytes, or more particularly from the diffusion of toxic proteoses
se Jour. Infect. Dis., 1917, 20, p. 185.
se Vaughan, V. C.: Protein split products in relation to immunity and disease, 1913.
57 Madsen, Th., and Noguchi, H.: Jour. Exper. Med., 1907, 9, p. 18.
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and albumoses into the circulation. With this object in view, we injected the
whole blood, defibrinated blood, red blood cells, leukocytes and serum of normal
persons and of patients suffering with lobar pneumonia-often moribund or
at the height of the disease. These experiments were done on rabbits, rats and
mice by both intravenous and intraperitoneal routes. Using graded doses cal-
culated per body weight of the animal, we were unable to detect any difference
in the toxicity of normal and pneumonic blood. Table 1 shows our results with
active serums. The normal serum (taken from a healthy medical student)
seems to be more toxic than the pneumonic. The pneumonic blood (Table 1)
was taken from a patient with a temperature of 102 F., pulse 128 to 140, res-
piration 40 to 65; consolidation of lower right lobe; increased tactile fremitus,
vocal resonance, bronchial breathing; no quinin was given.
TABLE 10
COMPARATIVE TOXICITY FOR MICE OF NORMAL PNEUMONIC SERUMS
Normal Pneumonic
Weight Dose Weight Dose I
in inCC Results in inCC
I
Results
Grams per Kilo Grams per Kilo
------------ ----I
16 1 Survived 16 1
I
Survived
20 2 Died, 48hours 18 2 Survived
19 6 Died, 48 hours 14 6 i Survived
15 10 Died, 72 hours 17 10 Survived
16 12 Survived 13 15 i Survived
15 15 DIed, 48hours 18 20 Survived
2Cl 20 Died, 48 hours 23 5() Survived
17 50 Survived
-
Mice were injected intraperitoneally with the sterile, active serum in proper dilution.
THE INCREASED TOLERANCE FOR QUININ IN PNEUMONIA
To begin an attack on the problem from another angle, a number
of observations were made to determine whether or not the pneumo-
coccus protein or substances present in the blood of pneumonia
patients would exert any neutralizing influence in relation to cinchona
poisornng.
The method consisted of mixmg lethal doses of various quinm salts with
nontoxic doses of pneumococcus protein or of pneumonic blood fractions (red
blood cells, leukocytes, defibrinated blood, etc.) and incubating for one hour
or more at 37 C. As pneumococcus protein, the washed and killed pneumo-
cocci obtained by centrifuging 500 c c of a 48-hour broth culture were used
suspended in 20 c c salt solution. The mixtures were injected intraperitoneally
into mice and rats. Several of the tests were done by injecting the dose of
cinchona 3 or 4 hours after the administration of the pneumonic substance.
The work was repeated several times, but our results were uniformly nega-
tive with this method.
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TABLE 11
THE NEUTRALIZING POWER OF PNEUMOCOCCIC PROTEIN AND OF PNEUMONIC SERUM FOR THE
TOXICITY OF CINCHONA DERIVATIVES
Weight Dose Dose of I,
in Substance inCC Cinchona Salt Drug in
I
Results
Grams per Grams
Kilo per Kilo I
--~ --------- ---------
12 Pneumococcus 10 Ethylhydroeupreln 0.7 Died, 24hours
protein hvdrochlorld
17 Pneumococcus 10 Ethylhydrocupreln 0.5 Died, 24hours
protein hydrochlorid
17 Pneumococcus 10 Quinin and urea 0.7 Died, 24hours
protein hydroehlorld
23 Pneumococcus ]0 Quinin and urea 0.5 Died, 24hours
protein hydroehlorld
20 Pneumonic 100 Quinin and urea 0.5 Died, 10minutes
serum hydrochlorid
15 Pneumonic 50 Quinin and urea 0.5 Died, 10minutes
serum hydrochlorld
14 Pneumonic 10 Quinin and urea 0.5, Died, 10minutes
serum hydrochlorid
Emulsion of dead pneumococci mixed with dose of drug was incubated at 37 C. for 3 hours
and injected Intraperitoneally into mice. Controls receiving emulsion alone survived.
Pneumonic serum. sterile and active, was injected intraperitoneally 4 hours before the
administration of the drug.
DISCUSSION
While our results on the study of the influence of quinin and urea
hydrochlorid, ethylhydrocuprein hydrochlorid, and allied cinchona
derivatives on the toxic substances obtainable from virulent pneumo-
cocci and pneumonic lungs have been largely negative, the question as
to the role of quinin in the treatment of pneumonia is still to be solved.
As to the particular problems here reported on, more refined methods
of study are to be devised. The action, if any, is not of a gross
physical or chemical order. Suggestive are the exceptional action of
quinin hydrobromid in combating the toxicity of pneumonic lung
exudate, and the somewhat paradoxical results of various cinchona
derivatives in antagonizing the hemolytic action of the same substance.
Further research in many directions is here indicated. It may be added
parenthetically that quinin hydrobromid and quinin dehydrobromid
have proved of considerable clinical usefulness in the treatment of lobar
pneumonia in man-a usefulness especially marked in Type II infec-
tious. The high pneumococcidal value of these salts was set forth in
our first study." We have shown elsewhere that quinin exerts a highly
specific and marked pneumococcidal action both in vitro and vivo.58
We have demonstrated its power of enhancing phagocytosis. 59 Its
58 Solis-Cohen, S., Kolmer, J. A., and Heist, G. D.: Jour. Infect. Dis., 1917, 20, p, 40.
ss Ibid., p, 101.
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property of reducing the plane of nitrogen metabolism described by
von Boeck'" and its general influence on antibody production may be
the factors involved. We are at present studying the latter problem.
SUMMARY
Pneumococci when dissolved in sodium choleate liberate a pre-
formed endocellular toxin which is lytic for erythrocytes. Our work
confirms the observations of Cole.
The liberation of this toxin in vitro is a most inconstant phe-
nomenon and is fraught with many technical difficulties.
Different preparations of the pneumotoxin vary considerably in
their toxicity for guinea-pigs, mice and rats. Anaphylactic shock
followed by immediate or delayed death, very severe dyspnea with
recovery or only mild respiratory disturbances with death in 24 hours
are observed after the intravenous injection into guinea-pigs (200-
300 gm. in weight) of doses varying from 9-2 c c of the pneumotoxin.
Rats are highly resistant to the pneumotoxin. This is in accord
with the findings of Novy.
The hemolytic power of the pneumotoxin was studied, using
guinea-pig erythrocytes. It was observed to be inconstant and not
always concomitant with the degree of toxicity.
Quinin and urea hydrochlorid, ethylhydrocuprein hydrochlorid,
and other derivatives of cinchona were found to exert no influence on
either the toxicity or the hemolytic activity of pneumotoxin.
Extracts of pneumonic lungs in the stage of gray hepatization were
prepared and found to be extremely toxic for guinea-pigs and rabbits
on intravenous and intramuscular injection. Convulsions, dyspnea and
immediate death followed the intravenous injection of guinea-pigs and
rabbits with doses of 0.7 c c and 0.2 c c, respectively, per kilo of body
weight.
Therapeutic doses of quinin bisulphate, quinin hydrochlorid and
particularly quinin hydrobromid prolonged to a recognizable extent the
lives of animals receiving 1 M.L.D. of pneumonic lung extract.
These pneumonic lung extracts were found to be markedly lytic for
erythrocytes, the M.H.D. being about 0.3 c c of a 1: 100 dilution with
the technic employed.
Quinin and urea hydrochlorid and ethylhydrocuprein hydrochlorid
had slight inhibitory effect on the hemolytic activity of the lung
eo Untersuchungen tiber die Zersetzung des Eiweisses im Thierkiirper unter dem Einllusse
von Morphin, Chinin und Arsenige Saure, 1871.
 at U
niversity of N
ew
 South W
ales on Septem
ber 12, 2015
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
ACTION OF QUININ, ETC., ON "PNEUMOTOXIN" 491
extracts when large, hemolytic doses of the drugs were used. Quinin
hydrochlorid, quinin hydrobromid, quinin bisulphate, and hydroquinin
hydrochlorid behaved in a reverse way, exhibiting marked inhibition
in nonhemolytic doses and no inhibition in hemolytic doses.
Substances toxic for rabbits, rats or mice could not be demon-
strated in the blood of patients suffering with lobar pneumonia.
Neither pneumococcus protein nor pneumonic blood was found
to have any neutralizing action on the toxicity of quinin salts for
animals.
We regard as a tenable hypothesis, the view that the pneumotoxin
may have the specific role of increasing the permeability of the walls
of the capillaries lining the alveoli, for the various normal blood pro-
teins, erythrocytes, leukocytes, fibrin and enzymes which go to make up
the pneumonic lung exudate; and that it furthermore tends to inhibit
the autolysis initiated by the proliferatig pneumococci, thus producing
toxic albumoses, proteoses and peptones. At the crisis this inhibitory
action is changed to an accelerating one and resolution then commonly
follows.
Neither the clinically beneficial action of cinchona derivatives in
the pneumonias nor the increased quinin tolerance of pneumonia
patients receives elucidation from the experiments reported; the results
being largely negative. Certain suggestive phenomena were observed
that further study may elucidate. That cinchona derivatives are spe-
cifically pneumococcidal and that they increase phagocytic activity has
been shown in previous papers. Whether their influence on general
metabolism and on general antibody production will suffice to explain
their further protective and curative influence remains to be deter-
mined.
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